In this cohort study of Merkel cell #carcinoma patients, a falling or negative titer indicated a 99.3% chance of remaining recurrence-free over 3 months, while a rising oncoprotein antibody titer suggested a 58% risk of recurrence by 12 months. ja.ma/4rifJeA